Discuss the role of regulatory frameworks in ensuring drug quality while promoting ease of business. What balance should be struck between regulation and innovation in the pharmaceutical sector?

Question

PocketIAS · Accepted Answer

Introduction India’s pharmaceutical sector is a global supplier of affordable medicines. Effective regulatory frameworks are essential to ensure drug quality, safety and efficacy, while also supporting a competitive and innovative business environment.

Role of Regulatory Frameworks in Ensuring Drug Quality

1. Standardisation and Compliance Regulations under the Drugs and Cosmetics Act, GMP norms and CDSCO oversight ensure uniform manufacturing standards. They prevent substandard and spurious drugs, safeguarding public health.

2. Licensing and Market Authorisation Approval pathways for new drugs and fixed-dose combinations create scientific scrutiny before market entry. This reduces the risk of unsafe formulations entering supply chains.

3. Quality Surveillance and Inspections Periodic audits, risk-based inspections and laboratory testing by central and state authorities help maintain post-market quality, especially in export-sensitive sectors.

4. Harmonisation with Global Norms Efforts to align with WHO GMP, US FDA and EMA practices enhance credibility, enabling Indian firms to compete globally.

Promoting Ease of Business

1. Digital and Single-Window Approvals Introducing online licensing, e-labs and common test standards reduces procedural delays and transaction costs.

2. Predictable Regulatory Timelines Time-bound reviews encourage investment in new drugs and biosimilars.

Balancing Regulation and Innovation

1. Risk-Based Regulation Stricter oversight for high-risk products and flexible pathways like accelerated approvals for critical drugs can balance safety with speed.

2. Encouraging R&D Ecosystems Regulatory clarity on clinical trials, data requirements and intellectual property incentivises innovation without compromising ethical standards.

3. Strengthening State–Centre Coordination Uniform enforcement reduces compliance burdens and enhances overall quality assurance.

4. Industry–Regulator Collaboration Stakeholder consultations can refine rules to support startups, biopharma ventures and advanced therapies.

✍️ Practice Mode

Write. Evaluate. Improve. Repeat.

The model answer is ready.

Comments (0)